CRVW · CareView Communications Inc
$0.04
At close · Sep 1
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company's net losses and working capital deficit raise substantial doubt about the Company's ability to continue as a going concern through August 12, 2027.”View the 10-Q filed Aug 12, 2026
Market Cap
$23.36M
Shares
583.88M
CRVW metrics
60 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$0.04
Market cap
$23.36M
Price action
19 metricsPrice change (1W)
-0.3%
Price change (30D)
-30.0%
Price change (3M)
-41.7%
Price change (6M)
+16.7%
Price change (YTD)
+250.0%
Price change (1Y)
+75.0%
Trailing year
Price change (5Y)
-79.4%
52-week high
$0.07
52-week low
$0.01
Change from 52-week high
-50.0%
Change from 52-week low
+250.0%
Annualized volatility
332.5%
Beta
-0.5
RSI (14D)
40.4
Price vs SMA 50
-26.8%
Price vs SMA 200
+3.1%
Avg volume (3M)
52,492
Relative volume
0.2
Average dollar volume
$2,743
Company
3 metricsSector
Healthcare
Industry
Health Information Services
Shares outstanding
583.88M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
2.5×
reciprocal yield 40.4%
P / book
—
FCF yield
0.7%
TTM · current market cap
Buyback yield
—
P / FCF
140.6
reciprocal yield 0.7%
P / operating cash flow
116.2
reciprocal yield 0.9%
Earnings yield
-11.7%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
—
Operating margin
4.4%
Trailing 12 months
Net margin
-28.9%
Gross profit (TTM)
—
Operating profit (TTM)
$418,731
Net income (TTM)
−$2.73M
Trailing 12 months
Diluted EPS (TTM)
$-0.01
FCF margin
1.8%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+19.6%
Year over year
Net income growth YoY
—
Revenue (TTM)
$9.44M
Trailing 12 months
EPS growth YoY
-100.0%
Shares change YoY
+318.9%
Year over year · more shares
Revenue CAGR (3Y)
+4.5%
Revenue CAGR (5Y)
+6.8%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
-46.3%
Debt / equity
—
Current ratio
0.1
EBITDA (TTM)
$565,565
Free cash flow (TTM)
$166,063
Quick ratio
0.1
Interest coverage
0.1
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$1.92M
Total assets
$5.90M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
$201,076
Capital expenditures (TTM)
$35,013
R&D (TTM)
$2.54M
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
26.9%
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
0
13F filer change QoQ
-1
Institutional ownership
—
Short interest
3 metricsShort interest
0.0%
Latest settlement · 1.3 days to cover
Days to cover
1.3d
Short-squeeze score
21 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
Flagged